Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3109/00016489709113448 http://scihub22266oqcxt.onion/10.3109/00016489709113448 9288223!ä!9288223 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Otolaryngol 1997 ; 117 (4): 618-22 Nephropedia Template TP {{tp|p=9288223|t=1997. Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy?|pdf=|usr=}}{{9288223}} gab.com Text Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy JO: Acta Otolaryngol http://www.kidney.de/pget.php?&tw=1&pmid=9288223 #FOAvip Fifty-three patients with bacterial treatment failure after a 10-day course of treatment with phenoxymethyl penicillin (pcV) for group A streptococcal (GAS) pharyngotonsillitis were randomly assigned to continued treatment with pcV, or to treatment with clindamycin instead. The patients were then followed for 1 year with throat cultures and clinical examination every third month and in the event of symptoms of sore throat. In the first 3-month period, 15/22 patients in the pcV group yielded one or more positive cultures for GAS, all of the same T-type as in the original throat culture, as compared to 3/26 in the clindamycin group (p < 0.001). All three cases in the clindamycin group were due to a new T-type and thus were re-infections. In the pcV group, owing to repeated treatment failure, 12/22 patients were switched to treatment with clindamycin within the 3-month period following the second treatment. During the remainder of the 1-year follow-up period, sporadic cases of GAS-positive throat cultures occurred in both groups, but there was no significant difference in frequency between the two groups. It is concluded that, in patients with GAS pharyngotonsillitis and failure after pcV treatment, a 10-day course of clindamycin can protect the patient from recurrence for at least 3 months and might be an alternative to tonsillectomy. Twit Text FOAVip Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy ????Acta Otolaryngol http://www.kidney.de/pget.php?&tw=1&pmid=9288223 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=9288223 #FOAvip English Wikipedia <ref>{{Cite pmid|9288223}}</ref> Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy? #MMPMID9288223 Orrling A; Stjernquist-Desatnik A; Schalen C Acta Otolaryngol 1997[Jul]; 117 (4): 618-22 PMID9288223show ga Fifty-three patients with bacterial treatment failure after a 10-day course of treatment with phenoxymethyl penicillin (pcV) for group A streptococcal (GAS) pharyngotonsillitis were randomly assigned to continued treatment with pcV, or to treatment with clindamycin instead. The patients were then followed for 1 year with throat cultures and clinical examination every third month and in the event of symptoms of sore throat. In the first 3-month period, 15/22 patients in the pcV group yielded one or more positive cultures for GAS, all of the same T-type as in the original throat culture, as compared to 3/26 in the clindamycin group (p < 0.001). All three cases in the clindamycin group were due to a new T-type and thus were re-infections. In the pcV group, owing to repeated treatment failure, 12/22 patients were switched to treatment with clindamycin within the 3-month period following the second treatment. During the remainder of the 1-year follow-up period, sporadic cases of GAS-positive throat cultures occurred in both groups, but there was no significant difference in frequency between the two groups. It is concluded that, in patients with GAS pharyngotonsillitis and failure after pcV treatment, a 10-day course of clindamycin can protect the patient from recurrence for at least 3 months and might be an alternative to tonsillectomy. |*Streptococcus pyogenes[MESH] |*Tonsillectomy[MESH] |Adolescent[MESH] |Adult[MESH] |Anti-Bacterial Agents/*therapeutic use[MESH] |Child[MESH] |Clindamycin/*therapeutic use[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Penicillin V/therapeutic use[MESH] |Pharyngitis/complications/*drug therapy/microbiology[MESH] |Recurrence[MESH] |Streptococcal Infections/*drug therapy[MESH] |Time Factors[MESH]Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an(epmc).pdf DeepDyve Pubget Overpricing